Natalya received her PhD in from Vanderbilt University in 2021; she joined the DDN team the same week she defended her thesis. Her work has been featured at STAT News, Vanderbilt Magazine, and Scientific American. As an assistant editor, she writes and edits online and print stories on topics ranging from cows to psychedelics. Outside of work you can probably find her at a concert in her hometown Nashville, TN.
Researchers are developing gene and cell therapies and prosthetics to help patients with blindness regain some vision. The first major prosthetic, the Argus II, was just discontinued. Where will the field go from here?
Researchers no longer think that proteins blindly swim through the cytoplasm hoping to bump into one another. Instead, they intentionally aggregate with other biomolecules, forming membrane free, transient organelles called condensates.
Clinicians, researchers, and communicators are developing more effective strategies to disseminate information about clinical trials to reach a wider audience. They ultimately expect that this will lead to more inclusive trials.
COVID-19 has gotten a little better at infecting cells and dodging antibodies with each set of mutations in new variants. Omicron is the best at dodging antibodies, but its modified structure sacrificed virulence for antibody resistance.
The FDA approved the first video game prescription in 2020. Since then, researchers are building more “prescription video games.” However, they aren’t sticking to 2D games; they are developing virtual reality experiences.
Mitochondria aren’t just the bean-shaped powerhouses of the cell. They are dynamic organelles that modify their structures to match their functions. Now, new research shows that mitochondrial morphology correlates not only with function, but also with symptom severity in autism.
Mitochondria are dynamic organelles that change their morphology in response to the energetic needs of the cell. But in some disorders such as autism spectrum disorder, mitochondria don't appropriately respond, and the resulting metabolic dysfunction contributes to symptom severity.